ATP 2016

DOSE CONSTRAINTS: HEART

• 16 pts with paracardiac and cardiac lesions • 30-36 Gy, 3# (70%) • D100%: 51.4 Gy • EQD2 (αβ3):108-204 Gy • BED3: 240 Gy

Bonomo et al. Radiol med 2013

• no cardiological symptoms or electrocardiographic abnormalities, even months after SBRT • 1 clinically irrelevant, pericardial effusion (PCE) at 3 months, disappeared at follow-up

Adebahr et al ,BJR, accepted 04/2015

German Cancer Consortium (DKTK)